Is Cancer Legal Care Legit?

Cancer Legal Care demonstrates a generally healthy financial trajectory, with consistent revenue growth over the past decade, increasing from $306,072 in 2014 to $626,197 in 2023. While the organization experienced a deficit in 2022 and 2023 (expenses exceeding revenue by $113,360 and $64,876 respectively), its asset base has grown significantly, indicating a build-up of financial capacity over time. The latest assets of $378,860 in 2023, compared to $120,161 in 2014, show a positive trend in financial stability. The organization's spending efficiency appears strong, particularly given the consistent reporting of 0% officer compensation across all available filings. This suggests a commitment to directing resources towards its mission rather than executive salaries. The relatively low liabilities, such as $26,698 in 2022 and $124,399 in 2023 (which is higher than previous years but still manageable relative to assets), further support a responsible financial approach. The NTEE code E86 (Legal Services) aligns well with its name, indicating a clear program focus. Transparency is excellent, with 13 filings publicly available and consistent reporting of key financial metrics. The absence of officer compensation is a notable positive for transparency and donor confidence. While the recent deficits warrant monitoring, the overall financial health, spending efficiency, and transparency of Cancer Legal Care appear commendable, especially considering its growth in services.